Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 8;11(1):161.
doi: 10.1038/s41598-020-80564-y.

False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance

Affiliations

False negatives in GBA1 sequencing due to polymerase dependent allelic imbalance

Jonas M den Heijer et al. Sci Rep. .

Abstract

A variant in the GBA1 gene is one of the most common genetic risk factors to develop Parkinson's disease (PD). Here the serendipitous finding is reported of a polymerase dependent allelic imbalance when using next generation sequencing, potentially resulting in false-negative results when the allele frequency falls below the variant calling threshold (by default commonly at 30%). The full GBA1 gene was sequenced using next generation sequencing on saliva derived DNA from PD patients. Four polymerase chain reaction conditions were varied in twelve samples, to investigate the effect on allelic imbalance: (1) the primers (n = 4); (2) the polymerase enzymes (n = 2); (3) the primer annealing temperature (Ta) specified for the used polymerase; and (4) the amount of DNA input. Initially, 1295 samples were sequenced using Q5 High-Fidelity DNA Polymerase. 112 samples (8.6%) had an exonic variant and an additional 104 samples (8.0%) had an exonic variant that did not pass the variant frequency calling threshold of 30%. After changing the polymerase to TaKaRa LA Taq DNA Polymerase Hot-Start Version: RR042B, all samples had an allele frequency passing the calling threshold. Allele frequency was unaffected by a change in primer, annealing temperature or amount of DNA input. Sequencing of the GBA1 gene using next generation sequencing might be susceptible to a polymerase specific allelic imbalance, which can result in a large amount of flase-negative results. This was resolved in our case by changing the polymerase. Regions displaying low variant calling frequencies in GBA1 sequencing output in previous and future studies might warrant additional scrutiny.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Comparison of exonic variant frequencies using (A) Q5 polymerase or using (B) TaKaRa polymerase. These are the first 216 samples with a suspected GBA1 exonic variant, initially sequenced using the Q5 polymerase and later repeated with TaKaRa polymerase. The top row shows histograms combining all exonic variants. The bottom row shows dot plots with variant frequencies per specific exonic variant. In normal circumstances, one would only expect a variant frequency around 50% and 100%. 44 samples contained two exonic variants (primarly p.[Asp179His;Glu365Lys] (D140H + E326K)), one sample contained three variants and one sample four. Frequencies below 30% are generally filtered out; the filter was customly set to 2% here. Variant details can be found in our previous publication.
Figure 2
Figure 2
Varying Ta and the respective amount of PCR product, using commercial human DNA (100 ng) with four different primer sets, split for the TaKaRa and Q5 polymerase. Ta = primer annealing temperature; PCR = polymerase chain reaction.

References

    1. Bandres-Ciga S, et al. Genetics of Parkinson's disease: an introspection of its journey towards precision medicine. Neurobiol. Dis. 2020;137:104782. doi: 10.1016/j.nbd.2020.104782. - DOI - PMC - PubMed
    1. Gan-Or Z, et al. Differential effects of severe vs mild GBA mutations on Parkinson disease. Neurology. 2015;84(9):880–887. doi: 10.1212/WNL.0000000000001315. - DOI - PMC - PubMed
    1. Hruska KS, et al. Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA) Hum. Mutat. 2008;29(5):567–583. doi: 10.1002/humu.20676. - DOI - PubMed
    1. Zampieri S, et al. GBA analysis in next-generation era: pitfalls, challenges, and possible solutions. J. Mol. Diagn. 2017;19(5):733–741. doi: 10.1016/j.jmoldx.2017.05.005. - DOI - PubMed
    1. den Heijer, J.M., et al., A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands. Mov Disord. (2020). - PMC - PubMed

Publication types